Thymic Imaging Pitfalls and Strategies for Optimized Diagnosis

Area of Science:

• Radiology
• Medical Imaging
• Oncology

Background:

• Thymic imaging is complex, with overlapping appearances for benign and malignant conditions.
• Computed tomography (CT), magnetic resonance imaging (MRI), and fluorine 18 fluorodeoxyglucose (FDG) PET/CT are key modalities, each with limitations.

Purpose of the Study:

• To review the diagnostic challenges and pitfalls associated with CT, MRI, and FDG PET/CT in evaluating thymic lesions.
• To emphasize the importance of appropriate modality selection and understanding technical limitations for accurate diagnosis and patient management.

Main Methods:

• Review of current literature and clinical practice regarding thymic imaging modalities.
• Analysis of specific limitations and potential errors for CT, MRI, and FDG PET/CT in thymic evaluations.
• Discussion of challenges in post-treatment imaging of thymic malignancies.

Main Results:

• CT has limitations in characterizing cystic lesions and differentiating thymic hyperplasia from tumors.
• MRI pitfalls include signal intensity ambiguities, artifact susceptibility, and diffusion-weighted imaging overlap.
• FDG PET/CT is not routinely indicated for initial diagnosis but is valuable for staging aggressive tumors and detecting metastases.

Conclusions:

• Awareness of imaging modality-specific pitfalls is crucial for accurate thymic lesion diagnosis.
• Proper selection and interpretation of imaging techniques, considering their limitations, enhance patient care and treatment guidance.
• Post-treatment imaging of thymic malignancies presents unique challenges, including artifact and recurrence differentiation.